These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 18701526)

  • 21. Argatroban anticoagulation in patients with a history of heparin-induced thrombocytopenia.
    Matthai WH; Hursting MJ; Lewis BE; Kelton JG
    Thromb Res; 2005; 116(2):121-6. PubMed ID: 15907526
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Argatroban anticoagulation for heparin induced thrombocytopenia in patients with ventricular assist devices.
    Pappalardo F; Scandroglio AM; Potapov E; Stepanenko A; Maj G; Krabatsch T; Zangrillo A; Koster A; Hetzer R
    Minerva Anestesiol; 2012 Mar; 78(3):330-5. PubMed ID: 22357371
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Excessive argatroban anticoagulation for heparin-induced thrombocytopenia.
    Reichert MG; MacGregor DA; Kincaid EH; Dolinski SY
    Ann Pharmacother; 2003 May; 37(5):652-4. PubMed ID: 12708939
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety and economic considerations of argatroban use in critically ill patients: a retrospective analysis.
    Kim SC; Tran N; Schewe JC; Boehm O; Wittmann M; Graeff I; Hoeft A; Baumgarten G
    J Cardiothorac Surg; 2015 Feb; 10():19. PubMed ID: 25879883
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Argatroban dose reductions for suspected heparin-induced thrombocytopenia complicated by child-pugh class C liver disease.
    Yarbrough PM; Varedi A; Walker A; Rondina MT
    Ann Pharmacother; 2012 Nov; 46(11):e30. PubMed ID: 23073302
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of bivalirudin and argatroban for the management of heparin-induced thrombocytopenia.
    Skrupky LP; Smith JR; Deal EN; Arnold H; Hollands JM; Martinez EJ; Micek ST
    Pharmacotherapy; 2010 Dec; 30(12):1229-38. PubMed ID: 21114390
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heparin-induced thrombocytopenia in patients administered heparin solely for hemodialysis.
    Murray PT; Hursting MJ
    Ren Fail; 2006; 28(7):537-9. PubMed ID: 17050234
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stroke in patients with heparin-induced thrombocytopenia and the effect of argatroban therapy.
    LaMonte MP; Brown PM; Hursting MJ
    Crit Care Med; 2004 Apr; 32(4):976-80. PubMed ID: 15071388
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recognition of heparin-induced thrombocytopenia and initiation of argatroban therapy after cardiothoracic surgery in the intensive care unit.
    Demma LJ; Paciullo CA; Levy JH
    J Thorac Cardiovasc Surg; 2012 May; 143(5):1213-8. PubMed ID: 22329977
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk factors for major bleeding in patients with heparin-induced thrombocytopenia treated with argatroban: a retrospective study.
    Hursting MJ; Verme-Gibboney CN
    J Cardiovasc Pharmacol; 2008 Dec; 52(6):561-6. PubMed ID: 19057393
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Argatroban for heparin-induced thrombocytopenia in hepato-renal failure and CVVHD.
    Dager WE; White RH
    Ann Pharmacother; 2003 Sep; 37(9):1232-6. PubMed ID: 12921505
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A case of heparin-induced thrombocytopenia associated with unexpected excessive argatroban anticoagulation after abdominal aortic aneurysm resection].
    Ichikawa M; Oue M; Okamoto A; Morishita H; Minatoya K; Ogino H; Miyata S; Imanaka H
    Masui; 2006 Feb; 55(2):188-92. PubMed ID: 16491897
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reducing harm associated with anticoagulation: practical considerations of argatroban therapy in heparin-induced thrombocytopenia.
    Hursting MJ; Soffer J
    Drug Saf; 2009; 32(3):203-18. PubMed ID: 19338378
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Argatroban as a primary or secondary postoperative anticoagulant in patients implanted with ventricular assist devices.
    Samuels LE; Kohout J; Casanova-Ghosh E; Hagan K; Garwood P; Ferdinand F; Goldman SM
    Ann Thorac Surg; 2008 May; 85(5):1651-5. PubMed ID: 18442558
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heparin-induced thrombocytopenia from venous thromboembolism treatment.
    Begelman SM; Hursting MJ; Aghababian RV; McCollum D
    J Intern Med; 2005 Dec; 258(6):563-72. PubMed ID: 16313480
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Argatroban and renal replacement therapy in patients with heparin-induced thrombocytopenia.
    Tang IY; Cox DS; Patel K; Reddy BV; Nahlik L; Trevino S; Murray PT
    Ann Pharmacother; 2005 Feb; 39(2):231-6. PubMed ID: 15632219
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Argatroban in extracorporeal membrane oxygenation.
    Beiderlinden M; Treschan T; Görlinger K; Peters J
    Artif Organs; 2007 Jun; 31(6):461-5. PubMed ID: 17537058
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of an argatroban-based purge solution in a percutaneous ventricular assist device.
    Laliberte B; Reed BN
    Am J Health Syst Pharm; 2017 May; 74(9):e163-e169. PubMed ID: 28438820
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dosing patterns and outcomes in African American, Asian, and Hispanic patients with heparin-induced thrombocytopenia treated with argatroban.
    Hursting MJ; Jang IK
    J Thromb Thrombolysis; 2009 Jul; 28(1):10-5. PubMed ID: 19016311
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of 2 nomogram-based strategies for dosing argatroban in patients with known or suspected heparin-induced thrombocytopenia.
    Arpino PA; Goeller AJ; Fatalo A; Van Cott EM
    Clin Appl Thromb Hemost; 2015 Apr; 21(3):260-5. PubMed ID: 23965335
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.